ALLEGRI, Lorenzo
 Distribuzione geografica
Continente #
NA - Nord America 1.298
EU - Europa 276
AS - Asia 117
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 1.697
Nazione #
US - Stati Uniti d'America 1.294
IT - Italia 61
UA - Ucraina 51
DE - Germania 45
CN - Cina 37
SE - Svezia 37
TR - Turchia 26
IN - India 23
IE - Irlanda 22
RU - Federazione Russa 21
VN - Vietnam 14
BE - Belgio 12
IR - Iran 12
RO - Romania 9
GB - Regno Unito 8
NL - Olanda 5
CA - Canada 4
HK - Hong Kong 4
TG - Togo 3
FR - Francia 2
CL - Cile 1
EG - Egitto 1
EU - Europa 1
FI - Finlandia 1
JP - Giappone 1
PL - Polonia 1
RS - Serbia 1
Totale 1.697
Città #
Fairfield 199
Chandler 133
Ashburn 131
Woodbridge 98
Seattle 87
Wilmington 82
Houston 69
Cambridge 60
Ann Arbor 57
Dearborn 30
Izmir 26
Jacksonville 26
Udine 26
Dublin 22
Beijing 19
New York 18
Princeton 17
Redmond 17
Ogden 16
Dong Ket 14
Brussels 12
Pune 12
Timisoara 9
Des Moines 7
Norwalk 7
San Diego 6
San Mateo 6
Augusta 4
Cagliari 4
Codroipo 4
Hong Kong 4
Latisana 4
Ardabil 3
Boardman 3
Curno 3
Dallas 3
Falls Church 3
Grafing 3
Hangzhou 3
Hefei 3
Leawood 3
Lomé 3
Monmouth Junction 3
Nanjing 3
Portici 3
Trieste 3
Cleveland 2
London 2
Mumbai 2
Phoenix 2
Sacramento 2
Tavagnacco 2
Toronto 2
Zanjan 2
Belgrade 1
Castiglione d'Adda 1
Cormeilles-en-Parisis 1
Guangzhou 1
Harbin 1
Jinan 1
Kashan 1
Kunming 1
Losser 1
Madinat an Nasr 1
Montreal 1
Nanchang 1
Napoli 1
New Delhi 1
Ottawa 1
Reana del Rojale 1
Sabz 1
Salzgitter 1
Shenyang 1
Taizhou 1
Trento 1
Venice 1
Warsaw 1
Washington 1
Wuhan 1
Yokohama 1
Totale 1.310
Nome #
Identification of tumorigenesis-related mRNAs associated with RNA-binding protein HuR in thyroid cancer cells 148
null 146
BET bromodomain inhibitor JQ1 modulates microRNA expression in thyroid cancer cells 121
Genomic Deletion Involving the IMMP2L Gene in Two Cases of Autism Spectrum Disorder 117
Human telomerase reverse transcriptase in papillary thyroid cancer: gene expression, effects of silencing and regulation by BET inhibitors in thyroid cancer cells 112
null 110
null 98
Evaluation of somatic genomic imbalances in thyroid carcinomas of follicular origin by CGH-based approaches 97
Tacrolimus Therapeutic Drug Monitoring in Stable Kidney Transplantation and Individuation of CYP3A5 Genotype 93
Successful and safe long-term treatment of cerebral aspergillosis with high-dose voriconazole guided by therapeutic drug monitoring 89
Quercetin improves the effects of sorafenib on growth and migration of thyroid cancer cells 66
EFFETTI DELL’INIBIZIONE DELLA RNA BINDING PROTEIN HuR NEL TUMORE TIROIDEO 65
BAZ1B is a candidate gene responsible for hypothyroidism in Williams syndrome 59
Plasma-Based Longitudinal Evaluation of ESR1 Epigenetic Status in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer 55
null 54
Longitudinal dynamics of circulating tumor cells and circulating tumor DNA for treatment monitoring in metastatic breast cancer 49
Critical involvement of calcium-dependent cytosolic phospholipase A2α in aortic valve interstitial cell calcification 46
Chiral ruthenium complexes: synthesis and evaluation of their anticancer activity 35
Cationic carboxylate and thioacetate ruthenium(ii) complexes: Synthesis and cytotoxic activity against anaplastic thyroid cancer cells 32
A paternally inherited 1.4 kb deletion of the 11p15.5 imprinting center 2 is associated with a mild familial Silver–Russell syndrome phenotype 31
Effects of dihydrotanshinone I on proliferation and invasiveness of paclitaxel-resistant anaplastic thyroid cancer cells 31
Effects of nutraceuticals on anaplastic thyroid cancer cells 30
Biological and molecular effects of bromodomain and extra-terminal (BET) inhibitors JQ1, IBET-151, and IBET-762 in OSCC cells 27
Anti-htert sirna-loaded nanoparticles block the growth of anaplastic thyroid cancer xenograft 23
Enantioselective Cytotoxicity of Chiral Diphosphine Ruthenium(II) Complexes Against Cancer Cells 19
Role of m6A RNA Methylation in Thyroid Cancer Cell Lines 15
GSK2801 Reverses Paclitaxel Resistance in Anaplastic Thyroid Cancer Cell Lines through MYCN Downregulation 12
The HuR CMLD-2 inhibitor exhibits antitumor effects via MAD2 downregulation in thyroid cancer cells 8
Effects of HuR downregulation on anaplastic thyroid cancer cells 4
A bird’s eye view on the use of whole exome sequencing in rare congenital ophthalmic diseases 3
Totale 1.795
Categoria #
all - tutte 5.922
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.922


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019131 0 0 0 0 0 0 0 0 0 19 70 42
2019/2020523 21 15 17 67 45 66 108 55 63 35 14 17
2020/2021350 28 22 25 41 21 36 10 36 24 20 52 35
2021/2022257 30 21 11 9 9 11 14 6 6 30 86 24
2022/2023283 26 35 6 35 33 56 0 25 40 8 9 10
2023/2024156 12 4 2 1 35 49 3 20 23 7 0 0
Totale 1.795